What's breaking now, across thousands of outlets.
Plus, news about Novonesis, Aspen, Fortrea and Northway. Alteogen and Novartis make a deal: The Swiss pharma is licensing Alteogen’s hyaluronidase enzyme, called ALT-B4, which is manufactured using a tech platform ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Dr. Lal should hold discussions with various State-level agencies and officials, study the health sector issues in depth, and submit an interim report with his observations and recommendations to the…
(MedPage Today) -- Thomas Steffens, DO, the Colorado surgeon accused of shooting at federal agents who were trying to arrest him in Florida, has been indicted on multiple charges, including attempted…
Plus, news about Novartis. 🤝 Pfizer turns over ADC: The New York pharma is giving Medicus Pharma co-development rights to a CD228-targeted antibody-drug conjugate known as PF-08046031, a…
Making Families Surrogacy Limited says cost, speed and cultural care are driving diaspora and international patients back to Nigeria in 2026 For years, the story of fertility treatment in Nigeria
THE Indian government is facing fierce opposition from health experts and food giants over proposed food warning labels.
More than 3,000 people have now died in the Democratic Republic of Congo’s Ebola Bundibugyo outbreak out of 6,250 confirmed cases, the Africa Centres for Disease Control and Prevention (Africa CDC)…
